Analysis of mutation, expression, methylation and dependency data from the Cancer Cell Line Encyclopedia61 failed to identify a correlation between mutational status of EP300/CBP and sensitivity to either HAT or bromodomain inhibition, including strong relationships to MYC genes (Supplementary Fig. 1). The gene discussed is EP300; the disease is cancer.